Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics said today that its ThyGenX and ThyraMir molecular thyroid tests have received coverage from four additional Blue Cross Blue Shield plans.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.